BacterioScan Validation in CLIA Certified Lab
Nuclea Biotechnologies, Inc. will be collaborating with Bacterioscan in the validation of the BacterioScan 216Dx instrument in a CLIA certified laboratory. This collaboration will focus on antimicrobial susceptibility testing for different strains of urinary tract infections.
The BacterioScan provides rapid detection and real-time quantification of bacteria in fluid using optical measurements, enabling researchers to quantify bacterial concentration and growth in a liquid in under twenty minutes. Nuclea Biotechnologies, Inc. is involved in developing and commercializing molecular oncology and metabolic syndrome diagnostics, and has recently expanded into infectious diseases.
The BacterioScan 216Dx Laser Microbial Growth Monitor is a compact, simple, and low-cost system for the rapid detection of Urinary Tract Infections capable of processing up to 16 samples simultaneously in a 90-minute 'walk-away' operation.
The instruments can also provide rapid phenotypic antimicrobial susceptibility testing and is used to detect and quantify bacterial concentrations that would typically fall below the detection limits of spectrophotometers and plate reader Optical Density measurements, potentially enabling more rapid selection of the right antibiotic treatment at the right dose.
At the moment, this instrument is at work in several world-class research hospitals and universities researching techniques for rapidly detecting antibiotic resistance and susceptibility in various types of bacterial infections. Initial work, including recent publications from the CDC and others, has indicated that the technology can reduce the time for selection of effective antibiotic therapy from 30+ hours to less than 3 hours, offering a potential breakthrough in addressing the worldwide urgent challenge of antibiotic resistance.
The BacterioScan instrument will be integrated within Nuclea’s CLIA laboratory in Pittsfield within the next three months.
Tags: Antibiotic Sensitivity, Urinary Pathogens, Antibiotic Resistance
Date Published: February 9, 2015
Source article link: Nuclea Biotechnologies Inc. » company contact details